Logo
Login
$BIO
$380.99 +$8.56 (2.3%) Close

Company Executives

$BIO Management Team

Mr. Norman Schwartz

Chairman of the Board

Chief Executive Officer

Age 75
Compensation $8.289M USD
Sex Male

Mr. Jonathan Divincenzo

President

Chief Operating Officer

Age 59
Compensation $4.314M USD
Sex Male

Mr. Roop Lakkaraju

Chief Financial Officer

Executive Vice President

Age 54
Compensation $3.775M USD
Sex Male

Ms. Colleen Corey

Executive Vice President

Global Human Resources

Age 63
Compensation -
Sex Female

Mr. James Barry

Executive Vice President

President - Life Science Group

Age 47
Compensation -
Sex Male

Mr. Sedat Evran

Executive Vice President - Global Supply Chain

Age 53
Compensation -
Sex Male

Mr. Edward Chung

Vice President - Investor Relations

Age -
Compensation -
Sex Male

Ms. Courtney Enloe

Executive Vice President

General Counsel

Secretary

Age 53
Compensation -
Sex Female

Mr. Michael Crowley

Executive Vice President - Global Commercial Operations

Age 63
Compensation $2.241M USD
Sex Male

Ms. Eva Anette Engelhardt

Executive Vice President

President of Clinical Diagnostics Group

Age 55
Compensation $2.231M USD
Sex Female

Mr. Rajat Mehta

Executive Vice President - Global Commercial Operations

Age -
Compensation -
Sex Male

Board of Directors

From the proxy statement filed Mar 25, 2026
Directors
6
serving now
Independent
4 of 6
stated in the proxy
Average tenure
11.8 years
from year joined
CEO also chairs the board
Yes
Norman Schwartz
Director Age On board Independent Committees Other public boards 2025 pay Source
Jeffrey L. Edwards
65 2017
9 years
 Independent
–Audit –Compensation –Legal & Regulatory Compliance
Kyntra Bio, Inc. $324,707
Gregory K. Hinckley
Lead independent director
 79 2017
9 years
 Independent
Compensation Committee
SI-BONE, Inc. $337,707
Melinda Litherland
68 2017
9 years
 Independent
–Audit –Legal & Regulatory Compliance
Rapid Micro Biosystems, Inc. $329,707
Arnold A. Pinkston
67 2017
9 years
 Independent
–Legal & Regulatory Compliance
None stated $309,707
Allison Schwartz
45 2022
4 years
 Not independent None stated None stated Not stated
Norman Schwartz
Board chair, CEO
 76 1995
31 years
 Not independent None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

3 disclosed in the proxy filed Mar 25, 2026
Allison Schwartz
Our director; Vice President, Global Supply Chain Clinical Diagnostics Group Operations since November 2024
$354,239
fiscal year 2025

Employment compensation: grant of 914 RSUs and base salary and bonus

Open in proxy
Allison Schwartz
Our director; Vice President, Global Supply Chain Clinical Diagnostics Group Operations since November 2024
$77,414
fiscal year 2025

Expatriate tax equalization payments (including gross-up) related to assignment in Canada until November 2024

Open in proxy
Allison Schwartz
Our director; Vice President, Global Supply Chain Clinical Diagnostics Group Operations since November 2024
$69,010
fiscal year 2025

Expatriate additional taxes payable and tax preparation fees (including gross-up) related to assignment in Canada until November 2024

Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans